CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycemic control in T1D and T2D
DOI 10.1055/s-0033-1341672
Bibliografische Angaben
Nachweis in CareLit
Autor:innenSJ Jacober, J Rosenstock, R Bergenstal, MJ Prince, Y Qu, J Beals
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objectives: The basal insulin analog LY2605541 (LY) is a PEGylated insulin lispro with a large hydrodynamic size which delays insulin absorption and reduces clearance, resulting in prolonged duration of action. Improved glycemic control with insulin generally results in weight gain. The present studies investigated how once-daily LY that showed glycemic control comparable with or superior to insulin glargine (GL), r…
Zitieren
Zitierempfehlung
SJ Jacober, J Rosenstock, R Bergenstal, MJ Prince, Y Qu, J Beals (2013) Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycemic control in T1D and T2D. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0033-1341672
Mit CareLit weiterarbeiten